BridgeMD
Compares treatment options for Ulcerative Colitis
Official title Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.
ClinicalTrials.gov ID: NCT05628701
What this study is testing
- What it's testing
- Background There are no prospective trials comparing the two main reconstructive options after colectomy for Ulcerative colitis, ileal pouch anal anastomosis and ileorectal anastomosis. An attempt on a randomized controlled trial has been made but after receiving standardized information patients insisted on choosing operation themselves.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Patients with Ulcerative colitis (UC) aged between 18 and 60
- Scheduled for or have previously undergone subtotal colectomy and ileostomy.
- Patients should have sufficient rectal compliance and controllable inflammation in the rectal using topical Mezalasin only.
You likely can't join if
- Rectal inflammation of Mayo Score \>1
- Poor sphincter function, perianal disease
- Uncertainty regarding UC diagnosis P
- Previous colorectal cancer or severe dysplasia
- Primary Sclerosing Colitis diagnosis
- \>2 year since subtotal colectomy
The study team makes the final eligibility decision.
Where it's taking place
- Gothenburg, Sweden
- Linköping, Sweden
- Solna, Sweden
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gothenburg, Sweden; Linköping, Sweden; Solna, Sweden; London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.